The British Veterinary Association has welcomed a report published by The Advisory Council on the Welfare Issues of Dog Breeding, which sets out eight priority welfare problems.
Commenting on the report, BVA President Carl Padgett said: "We welcome the Dog Advisory Council's report which highlights key welfare issues of dog breeding and makes sound, practical recommendations for addressing them."
The eight priority problems addressed are:
Mr Padgett continued:"The Dog Advisory Council has covered these high priority concerns in some detail. I am pleased that the recommendations give strong support to screening programmes including the BVA/KC schemes for hip and elbow dysplasia and syringomyelia and that they suggest ocular examination under the BVA/KC/ISDS eye scheme should be regarded as routine for all dogs used for breeding.
"I am also delighted that the Council has recognised the value of using a reputable puppy contract, highlighting the puppy contract and puppy information pack (PIP) recently launched by the BVA Animal Welfare Foundation and RSPCA. The contract and PIP arm buyers with the knowledge to give themselves the best chance of getting a fit, healthy and happy, well socialised pet to join their household and they have been designed to help good breeders demonstrate the care and attention they have devoted to their puppies' breeding and upbringing.
"We must all continue to work together to address these welfare challenges and keep up the momentum to improve dog breeding."
The majority of posters, leaflets and other displays in veterinary practice waiting rooms are more effective at building ambience than increasing the turnover of the practice or selling a particular product or brand, according to a new survey carried out by veterinary marketing agency TMA.
The national survey of more than 100 veterinary practice managers found that:
TMA says it believes practices are missing out on a major marketing opportunity by not changing their displays more often, not being more selective about what is displayed, and not making the most of interactive or digital display technology.
Helen Cawthra, Managing Director of TMA believes that product manufacturers are also missing out on a major opportunity. Significantly less than half of all display and point-of-sale material in vets' waiting rooms is provided by suppliers. On average, 64% is sourced by the veterinary surgeons themselves.
Helen said: "Two thirds of respondents claim that they hardly get any materials from suppliers. The same number claim they would be more likely to put up more if they were provided with it.
"It is all very well building ambience and providing loyalty but in today's market, it is important that vets take hold of every opportunity to generate revenue in every way possible. Vets and the manufacturers are both missing out."
Companion Care Vets has announced that it will open its 100th surgery in Llantrisant, South Wales on 7th September 2012.
The surgery will reside within the Pets at Home store in Llantrisant and will be owned and managed by Joint Venture Partner Rhian Bullock who has returned home to Llantristant after working and studying for many years in the USA.
Jane Balmain, Managing Director, Companion Care Vets said: "2012 has been quite a year for the business, we were named as one of The Sunday Times 100 Best Companies to Work For, becoming the first veterinary group to be awarded this accolade. Our growth has been such that we have recently launched a dedicated recruitment website, we have employed our 1,000th team member and to be opening our 100th surgery is testament to the hard work and dedication of our fantastic team."
Companion Care now has 117 Joint Veterinary Partners, 96 of whom are veterinary surgeons, 13 veterinary nurses, 7 practice managers and a receptionist and a further 953 colleagues employed by the group. The company says it has doubled in size in the past three years and is on track to do so again by 2015.
Jane said: "At present the majority of our surgeries are part of the Pets at Home in-store model but there are already five very successful standalone surgeries and the standalone surgery network plan is being developed to cater for those vets and veterinary nurses whose preference is to have a more traditional standalone surgery."
Rhian said: "A local girl, I have just moved back to Llantrisant and am really excited to be running my own practice in an area that I love. I set myself very high clinical standards and always involve the client in treatment and their pet's wellbeing. There is nothing that satisfies me more than well animals and happy clients."
Rhian and her team are involving the local community in the opening and will have guests from local branches of the Dogs Trust and the Cats Protection League present on opening day raising funds and joining in the celebrations.
The RCVS has announced the members that will comprise its new Audit and Risk Committee, which was set up following recommendations in the RCVS Overspend Review Group's report (otherwise known as the McKelvey Report).
The Audit and Risk Committee will support RCVS Council in meeting its oversight responsibilities, including:
Its members are:
Non-Council membersElizabeth Butler (Chairman) is a practising Chartered Accountant who has held a wide variety of non-executive appointments, bringing both professional expertise and a depth of understanding of risk and governance. Among other roles, she has chaired the audit committees of the Royal College of Nursing and Hyde Housing Association, and currently chairs the audit committees of the Electoral Commission and the Local Government Boundary Commission for England, she is also chairman of Lewisham Healthcare NHS Trust.
David Hughes is a chartered accountant and a former senior partner who has extensive expertise in financial reporting, accounting, auditing, risk management and governance issues. He is currently a Non-Executive Director and Chairman of the Audit Committee for the Highways Agency and a member of the Department for Transport Audit Committee.
Judith Rutherford has five years' experience as a Non-Executive Director and as a member of the Audit Committee in a community Healthcare and Primary Care Trust within the regulated environment of the NHS. She is currently Director of an organisation that provides interim management and consultancy to the private and public sectors.
RCVS Council membersRichard Davis is a Privy Council-appointed member of RCVS Council. He farms 104 hectares in North Bedfordshire and has been a director of First Milk Ltd for seven years. He has also been a director of Westbury Dairies Ltd, where he was Chairman of the Audit Committee. Richard has served on the audit committee of Assured Food Standards (Red Tractor) for the last six years and served as the Chairman of Assured Dairy Farms for six years (the scheme sets, audits and monitors production, welfare and environmental standards for most UK processors, and over 12,000 dairy farms).
Lynne Hill MRCVS is Chief Executive of Langford Veterinary Services Ltd, University of Bristol, and was previously Head of the Clinical Services Department at the Royal Veterinary College. Prior to that, Lynne was European Marketing Manager for Hill's Pet Nutrition. She is an elected member of RCVS Council and was President in 2005-6.
The non-Council members of the Committee were appointed by a panel chaired by Sir David Barnes, Chairman of the Governance Review Group.
The new Committee, which is accountable to Council and will report at least annually, will meet for the first time in early autumn.
Jacqui Molyneux, RCVS President said: "I am pleased that the new Audit and Risk Committee is now in place. It should offer reassurance to both members and the public that the framework via which Council's activities are scrutinised is robust."
The organisers of Rabbit Awareness Week (15th-21st September) are calling on veterinary practices to show their support and sign up to its free health check scheme, to highlight the importance of preventative healthcare for rabbits.
This year's RAW campaign is focusing on vaccinations, to protect one of Britain's most popular small pets from two painful and potentially fatal diseases, myxomatosis and Rabbit Haemorrhagic Disease (RHD).
Participating practices will receive free support packs to help them advertise and run their own health check events, as well as care advice materials to give out to clients who bring their rabbits in.
Rabbit Awareness Week 2012 is backed by Burgess Excel and various partners, including MSD Animal Health, RSPCA, PSDA, Blue Cross, Wood Green The Animals Charity and RWAF (Rabbit Welfare Association & Fund).
Justin Heaton, Head of Marketing at Burgess Pet Care, said: "This September, RAW aims to promote the importance of preventative healthcare, including regular vet health checks and vaccinations for rabbits, to protect them from disease. Rabbits are at risk from myxomatosis and RHD and this year's goal is to highlight how important vaccinations are against these diseases and encourage owners, particularly those not currently registered with a veterinary practice, to bring their rabbits in for free veterinary health checks and vaccinations.
"RAW partners believe that many rabbit owners are unaware that injections for rabbits are a necessity for them to live a long and healthy life. The average rabbit should live at least 8-12 years, but one in three pet owners (38 per cent) estimate a rabbit's maximum lifespan to be five years*. Along with meeting their dietary, behaviour, environment and companionship needs, Britain's rabbits' must be protected from pain, suffering, injury and disease to ensure they are healthy and happy. Vaccinations are an important part of responsible pet ownership and will help to ensure that rabbits live a long and healthy life."
If you are interested in supporting RAW 2012, by hosting rabbit healthcare clinics at your veterinary surgery, visit www.rabbitawarenessweek.co.uk to order your free support kit and register your event.
Invicta Animal Health has launched a new identification service for ChroMyco Duo dermatophyte kits in partnership with Axiom Veterinary Laboratories.
Veterinary practices can now send positive ChroMyco plates to Axiom and receive a species identification report for the specially discounted price of £8.00.
Rob Watkins, Managing Director of Invicta Animal Health said: "We are delighted to launch this service in response to customer feedback. This enables practices to gain a positive dermatophyte diagnosis in as little as three to six days so that treatment can be commenced promptly. Then, by sending the plate to Axiom, the actual species can be subsequently identified.
Axiom, with its innovative microbiology department and dedication to quality combined with its reliable network of courier services and postal processing systems are the ideal laboratory to provide this service".
Submission forms are available free of charge from Invicta Animal Health 01403 791313. ChroMyco Duo dermatophyte test kits are available from wholesalers and priced at £25.00 for 5 kits.
Vetoquinol has announced the launch of Chrysanphyton, the latest addition to its range of Equistro feeding stuffs for horses.
Vetoquinol says Chrysanphyton is recommended for horses where support of a normal blood flow to the hoof is important. It contains Chrysantellum americanum, blackcurrant and hazelnut extracts which, according to the company, provide a rich source of nutrient bioflavanoids and vitamins.
The recommended administration of Chrysanphyton is 10ml twice a day in horses (500kg) and 5ml twice a day in ponies with the 1000ml pack lasting 50 or 100 days respectively.
A product information sheet is available on the Equistro website www.equistro.co.uk
For further information contact your local Vétoquinol Territory Manager.
Vetoquinol has published a waiting room poster which highlights canine pain, to support Cimalgex.
Robert Simpson, Product Manager for Cimalgex said: "This poster aims to highlight that pain may not be obvious to pet owners and that signs which the owner may believe to be age related, for example stiffness, may actually be behavioural signs of pain. The most common sign of pain is a change in behaviour and so this is an area which we believe needs to be highlighted to the pet owner1.
"This new poster uses a strong image to catch the pet owner's attention which, when combined with its simple message, will prompt the pet owner to ask for further information from the veterinary practice regarding pain to ensure the overall wellbeing of their pet. This poster complements our client leaflet in helping the veterinary practice to assist the pet owner to spot signs of pain which may not be very obvious."
To find out more or to request a waiting room poster for your practice please contact your Vetoquinol Territory Manager or call 01280 825424.
Reference
1. Hellyer P. et al. AAHA/AAFP Pain Management guidelines for Dogs and Cats. J. AM Anim Hosp Assoc 2007; 43: 235-248.
The RCVS welcomed 15 veterinary surgeons who passed the RCVS Statutory Examination for Membership with a registration ceremony held on Monday at Belgravia House.
The RCVS Statutory Examination for Membership is open to veterinary surgeons with a veterinary degree gained outside the UK that is not recognised by the RCVS, and who therefore cannot join the RCVS Register. Candidates for the exam must also score at least 7.0 in the academic International English Language Testing System (IELTS) test, which is comparable to requirements for entry to UK veterinary degrees and those of other professional regulators.
RCVS President Jacqui Molyneux said: "Your success is remarkable - especially for those whose first language is not English. The veterinary profession in the UK is small and welcoming, and you will find valuable support offered by the different members of the veterinary team as well as from professional organisations."
Registering at the ceremony was Mr Vahidreza Ardani, who qualified from the Islamic Azad University in Iran, where he practised for ten years as a large animal vet. He said: "It took me nearly three years of study to prepare for the IELTS [English language] exam. I have also been seeing practice here for the past two and a half years, including at the small animal hospital at the University of Glasgow. I hope now to find work at a small animal practice."
Ms Olga Woolmer, who qualified from Perm State Agricultural Academy, Russia, also registered. Olga saw practice in several UK small animal and equine practices as preparation for the exam, whilst also working as an animal technician. She said: "I'm really grateful to all the practices that let me see practice. In particular, Burghley Veterinary Centre at Stamford helped me a lot in learning about what veterinary clients in the UK expect and how to sound confident when I give advice - which ultimately is best for the patient. It's great that I will soon be able again to do the work that I've trained so hard for."
Bulk milk surveillance for stomach worm exposure in dairy cows has found high levels in 68% of herds, with "probable sub-clinical effects on health and production", according to Pfizer Animal Health.
Between September 2011 and March this year, 449 milk samples submitted by dairy vets and SQP animal health advisers were analysed independently for Pfizer VPS.
Pfizer VPS vet Andrew Montgomery says that stomach worm (Ostertagia ostertagi) is the species identified most often in dairy cows1,2. and known to suppress appetite3: "Numerous trials have found a yield response to worming treatment, typically in the region of 1kg/cow/day."4
"At 25p/litre, this would be worth £76/cow over a 305-day lactation, or about £16,500/year in a typical 200-cow herd. Some trials have also identified improvements in reproductive performance although this remains to be proven absolutely."4
When test results indicate that worming is justified, Andrew recommends a moxidectin pour on treatment in the late dry period to maximise the gain over the highest yielding, early part of lactation.
The bulk milk surveillance programme is ongoing, and free Pfizer test kits are available from participating VPS animal medicine suppliers and veterinary practices.
References
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.
Ceva Animal Health has produced a leaflet to help horse owners understand the cause, diagnosis and management of equine back pain.
The company says the management of back pain in the horse can be a particular challenge to vets and a source of frustration for owners. Early diagnosis is likely to be associated with a more favourable outcome but it's important to ensure that other causes of pain and poor performance such as lameness, are not contributing to the horse's clinical signs.
'Understanding back pain' explains the anatomy of the back, as well as the clinical signs of back pain, and how it is diagnosed, including the treatment options and the general prognosis. Copies of the new leaflet are available, free of charge, from your Ceva sales representative. Leaflets on 'Understanding bone spavin', 'Understanding navicular disease', 'Understanding sacroiliac disease' and 'Equidronate discharge instructions', are also available.
For further information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Organisers of the Vet Charity Challenge are calling for more people to take part in the event, to join the 100 that are already set to walk, run, cycle, kayak and orienteer around the grounds of the Royal Agricultural College in Cirencester on On 15th September.
Gavin Mitchell from BCF Technology said: "We have entered two teams and already have a £100 bet on which of our teams will gain the most points on the day. This rivalry has certainly had a positive influence on the amount of training we are all doing to prepare for the challenge. The teams are out cycling after work and off for runs during lunchtimes."
Gavin added: "We are keen to ensure we beat the other teams such as those from Vets Now, and Clent Hills Vet Group. No pressure!"
Teams are also starting to gather sponsorship for the three chosen charities of SPANA, Hounds for Heroes and Pet Blood Bank. The team that raises the most amount will win a day's in-practice imaging training with the BCF in-house vet Kimberly Palgrave, BS BVM&S GPCert(DI) MRCVS.
Andrew Groom from Kruuse said: "This is a great focus to help get fit over the summer months, build team spirit within a practice and enhance a practice's profile locally, as well as raising money for some great causes. There is still room for a few more teams, so we urge practices to not wait any longer and sign a team up now."
For more information visit www.vetcharitychallenge.co.uk, call 01727 859 259 or find it at www.facebook.com/vetcharitychallenge
The Kennel Club is hosting its second Puppy Awareness Week to help improve the health and lives of dogs around the UK, and is seeking assistance from the veterinary profession.
Puppy Awareness Week is taking place from 8th - 14th September and aims to help people find a healthy, happy puppy that is right for their lifestyle, whilst raising awareness about the plight of puppies and breeding bitches born into cruel puppy farms.
To help, veterinary surgeons and nurses are being asked to join in the week, putting up posters and literature in client waiting areas, and selling Puppy Awareness Week badges for £2, which will go to the Kennel Club Charitable Trust.
Caroline Kisko, Kennel Club Secretary said: "It is vitally important that we spread the word about buying puppies responsibly. At veterinary surgeries there is a captive audience of animal lovers and we can't think of anyone better to communicate with. Not only are a vet's clients animal lovers and as such, potential new dog owners, but they may also make great champions of the cause, spreading the message about buying a puppy responsibly further afield.
"Sadly, we are seeing tens of thousands of puppies born each year suffer as puppy farms churn out litter after litter of undernourished and badly cared for puppies, and then selling them on to unsuspecting owners through pet shops, newspaper ads, online adverts and various other means. With help from veterinary practices we want to provide information throughout Puppy Awareness Week to help people understand how to buy a healthy, happy puppy, and to raise money for the Kennel Club Charitable Trust, which supports charities and organisations that are making dogs' lives better."
To get involved in Puppy Awareness Week and receive literature and Puppy Awareness badges, contact the Kennel Club press office at press.office@thekennelclub.org.uk.
Puppy Awareness Week will kick off at Pup Aid on September 8th in Primrose Hill, London and will run until 14th September. To find out more, visit www.thekennelclub.org.uk/paw.
Norbrook Laboratories Ltd has announced the launch of Pestigon, a fipronil spot-on solution for cats and dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Pestigon offers a fast-acting and long-lasting treatment for cats and dogs suffering from flea and tick irritations. The new product will have an immediate effect against flea infestations and will kill ticks within the first 24 - 48 hours of application. Fipronil is a tried and tested ingredient with proven efficacy against fleas and ticks. Pestigon provides a fast-acting treatment whose effectiveness will continue against new infestations of fleas for up to 58 days on dogs and 37 days in cats and against ticks for up to 30 days in dogs and 21 days in cats."
To coincide with the launch of Pestigon, Norbrook has rebranded its Permaguard household spray which is now available with 12 month protection.
Rebekah said: "The total life cycle of a flea can last from a couple of weeks to several months. Only adult fleas live on cats or dogs while the eggs, larvae and pupae can be found around the house in carpet, furniture, bedding etc for up to a year or more. It is therefore crucial that pet owners treat the household to break the life cycle and ensure effective and lasting flea control. Pestigon and Permaguard together will give pet owners a complete treatment."
Pestigon range offers 5 alternatives for cats and dogs depending on size and comes with colour co-ordinated pipettes available in packs of 3, 6 and 24 to allow for single or multiple pipette dispensing.
Norbrook's Small Animal Brand Manager, Michelle Jones said: "Pestigon is licensed as a POM-V product and will be sold exclusively through veterinary practices. We have produced a range of marketing materials for veterinary practices to help them offer support on flea and tick control in the home to their customers."
Orders for Pestigon and Permaguard can be placed through your Norbrook representative now.
Boehringer Ingelheim Vetmedica has launched a new Canikur Pro website - www.canikurpro.co.uk - to provide pet owners with advice on digestive upset and offer a quick reference guide to using Canikur Pro.
The site offers information about the common causes of digestive upset, including dietary indiscretions, stress due to a change in circumstances and underlying gut problems.
The site also contains information about how Canikur Pro works, how to give the product and where to buy it, plus tips for supporting the recovery of a dog's gut health such as providing a constant supply of fresh water, offering a bland diet and providing access to outside areas to reduce accidents.
In addition, the site contains a 'veterinary only' area where veterinary professionals can download client materials.
The Webinar Vet has released the results of a survey which shows that its members are far exceeding their 35 hour CPD target.
Launched just over two years ago, The Webinar Vet was the first company in the UK to specialise in web-based CPD for vets and now has nearly 1000 members from around the globe.
The Webinar Vet founder Anthony Chadwick MRCVS said: "Our members average over 60 hours of online CPD per year. Indeed several members are exceeding 100 hours a year including workshops, and some have even recorded over 200 hours of total CPD!
"There will always be a need for workshop CPD, but most vets and VNs can get the majority of the updates and information they need online. However we believe that in many cases it's not a simple swap - the convenience of online CPD means that many vets and VNs are earning more total hours, which can only be a good thing for the profession.
"Many vets and VNs are juggling busy family lives with work in practice, and the convenience of viewing and participating in webinars from your own home or in a practice lunch break is both cost and time saving, not to mention the reduction in carbon footprint."
Virbac Animal Health is calling on practices to prepare for Canine Prostate Awareness Month (CPAM), being held by the company in November to highlight the prevalence of the disease and to encourage owners and practices to test for it.
Last year, 400 practices sign up to support the event, and the company says that feedback from many taking part confirmed a significant lack of understanding among clients as to the risk of prostate disease in dogs.
Canine Prostate Awareness Month is timed to coincide with 'Movember', when thousands of men grow moustaches to raise funds for male prostate and testicular cancer. During the month, Virbac is providing promotional materials including dog leads; educational and display materials and a press release for local media.
Chris Geddes MRCVS, Virbac Product Manager, said: "With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)¹, we wanted to give practices a reason to highlight the risk and encourage owners to test for it. Timing CPAM to coincide with Movember seemed a good way to interest dog owners at a time when some might be considering the state of their own prostate.
"The support we received last year confirmed that it was a topic which practices were keen to discuss with dog owners so we're already planning to make the initiative even bigger and better this year."
Stephen Bamber, Principal at participating practice Warwickshire-based Avonvale Vets, added: "CPAM was an attractive campaign as it was a bit different. It offered the opportunity to see some of our older patients with other, less obvious pathologies. Non-symptomatic testicular tumours in particular surfaced in the checks we did. Clients generally had little idea about dogs' prostates so it gave us a good platform to discuss prostate disease with them."
Virbac has introduced OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, available from three UK diagnostic laboratories. The company says it's a cost-effective, precise and reliable alternative to rectal palpation. Virbac also offers Ypozane, a tablet treatment for BPH which takes effect within a week and lasts for up to six months.
Chris added: "BPH is an unpleasant condition occurring in nearly all entire dogs as they get older, but one which is entirely treatable. We hope that, by running our Prostate Awareness Campaign at a time when the media spotlight is already on the dangers of prostate cancer in men, we can help spread the message that owners should be monitoring older dogs for signs of prostate disease."
For further information on the Prostate Awareness Campaign, email cpam@virbac.co.uk; contact your Virbac Territory Manager or contact the company direct on 01359 243243.
Dechra Veterinary Products has published a range of case studies to support its new campaign focused on the diagnosis and treatment of otitis externa.
The studies have been written by Referral Dermatologist Sue Paterson MA, VetMB, DVD, DipECVD, MRCVS, RCVS European Specialist in Veterinary Dermatology and Peter Forsythe BVM&S, DVD, MRCVS, RVCS Specialist in Veterinary Dermatology.
Developed as part of the Time to Change campaign, the real-life examples feature a series of problems and solutions associated with otitis, supported by clear images and photomicrographs.
Larry King, Senior Brand Manager, Dechra Veterinary Products, said: "We have created a range of in-depth case study materials for use by vets and vet nurses which will support identification and management of otitis externa, one of the more frequent conditions seen in general practice.
"As veterinary professionals are aware, otitis is common and can be challenging to diagnose and treat. These studies address individual cases and demonstrate how the Dechra dermatology range can be used effectively.
"Topics covered in the case studies include the types of otitis presented by each animal, how individual organisms were identified using cytology and how long treatment was continued."
The case studies, which feature Malassezia, staphylococcal and Proteus infections, also discuss the underlying causes and steps taken after treatment with Canaural and various ear cleaners.
The Time to Change campaign has been launched to support a best practice approach to otitis which includes the identification of the organisms causing infection through cytology, support the selection of the correct treatment and assist with educating clients on how to apply and use products correctly.
For further information visit www.dechra.com/timetochange. The website also highlights the benefits of Dechra Veterinary Products' range of topical treatments and ear flushes, including Canaural, CleanAural, CerumAurual, TrizAural and MalAceticAural.
Petplan has launched a new service to pay vet claims direct to practice bank accounts via BACS.
Petplan says it pays out nearly £3 million in claims each week, which is the equivalent of paying £35,000 per year to each veterinary practice in the UK. Paying practices by BACS means that the money is received faster and there is no administration required by the practice, freeing up more time for clinical work.
As part of this new service, practices also receive a detailed statement by email providing a breakdown of the client claims the payment relates to.
To register to receive claim payments by BACS, visit petplanvet.co.uk and complete an online form.
Simon Masding, Petplan's Head of Sales and Partnerships said: "Petplan has a great relationship with vet surgeries and we know in the last few years some practices have had increasing pressure on cash flow due to reduced footfall and rising costs. We are constantly looking for new, smarter ways of working to help our partners and wanted to get claim payments to vets even faster."
Petplan's Vet of the Year Brian Faulkner said: "Most people become vets because they love to work with animals, and the paperwork is merely a downside of the job. It's great to see that Petplan has reduced the time we have to dedicate to admin, meaning we can concentrate on the important things, like improving the health of Britain's pets."
For more information visit www.petplanvet.co.uk
A team of top equine vets is aiming to raise £125,000 for the Society for the Protection of Animals Abroad (SPANA) by travelling 3000 miles through Europe by motorbike between 22nd August and 9th September.
Sponsored by Elanco Animal Health, the seven-strong team is planning to travel through Belgium, the Netherlands, Germany, Switzerland, France, Italy, Morocco and Spain and deliver lectures to eight European and African veterinary schools in just two weeks.
Led by Professor Derek Knottenbelt from the University of Liverpool, the team also includes Professor Josh Slater from Royal Veterinary College, Dr John Burford from the University of Nottingham, Dr Caroline Hahn from the University of Edinburgh, Dr Michael Hewetson from the University of Helsinki, Ms Joanne Suthers from the University of Liverpool and Dr Edmund Hainisch from the University of Vienna. They are being supported by Jeremy Hulme, chief executive of SPANA, Nic Van Gelder, fundraising and supporter care administrator at SPANA and Cerian Stephens.
All money raised will provide SPANA with diagnostic and surgical equipment for the charity's veterinary clinics for working animals in Mali and Mauritania and for the further development of the Bamako Disabled Riding Centre in Mali.
Mike Brown, Elanco's UK and Ireland country director said: "We are delighted to be sponsoring the Vets with Horsepower European Tour which will raise vital funds for working animals in some of the world's poorest countries. This is just one of the many worthwhile initiatives we are supporting in 2012 which focus on alleviating world hunger, spearheading agricultural leadership, enhancing the human-animal bond and caring for the environment."
For further information on the Vets with Horsepower European Tour visit www.spana.org/horsepower.
The Badger Trust's legal challenge to Defra's plans for targeted badger cull pilots has failed in the High Court on all three grounds.
Whilst the RSPCA has expressed its disappointment, the British Veterinary Association and British Cattle Veterinary Association have welcomed the judgement.
BVA President Carl Padgett said: "We are pleased that the High Court has ruled Defra's policy lawful and that the pilot badger culls can now go ahead.
"The BVA and BCVA believe that the government's approach has been robust and justifiable as it is based on our current scientific knowledge.
"Bovine TB is a devastating disease and we must tackle the disease in wildlife alongside cattle controls if we are to get on top of it."
David Bowles, the RSPCA's Director of Communications, said: "We are bitterly disappointed that the UK Government in England is ploughing on with plans to kill badgers but the fight is not over yet.
"We believe culling is not a long-term, sustainable solution and will be of little help in reducing the disease - perhaps even making things worse in some areas. It will wipe out huge numbers of this much-loved species, virtually eliminating badgers from these areas, including many animals which are healthy.
"It is not as if there aren't alternatives to a cull. Vaccination could be a more effective and sustainable way of dealing with the disease, and one which does not involve killing most of the badger population in very large areas of the countryside."
Virbac Animal Health has launched Speed Leish K, a diagnostic test for canine leishmaniosis.
Speed Leish K detects antibodies directed against the kinesins of leishmania using a Kinesin Capture Complex (KCC), a complex of recombinant proteins with strong immunogenic power at all stages of infection. Virbac says that in trials the test has demonstrated 98.5% overall accuracy.*
Virbac Product Manager Simon Boulton MRCVS said: "Leishmaniosis presents a growing threat to UK dogs, particularly those which travel with their owners on holiday to regions where the disease is endemic.
"Speed Leish K should be used as part of the primary CaniLeish vaccination protocol in animals previously at risk of exposure to ensure only health animals are vaccinated. The test can also be used to screen for the disease in animals suspected to be infected."
Speed Leish K is presented in kits of two or six tests and can be stored for 24 months at room temperature.
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
Vetoquinol has launched a pain monitoring system along similar lines to those used in humans, which can be used by vets and owners to measure pain over time and assess different treatment strategies in dogs.
According to the company, it is widely accepted that all mammals experience pain1and that under treatment is a big issue. Guidelines in treating human pain issued by NICE state that: 'evidence suggests that pain caused by advanced disease remains under-treated'. Veterinary medicine faces a harder task in recognising and treating pain effectively as it relies on behaviour rather than verbal communication.
In human medicine, Client Specific Outcome Measures have been used to assess treatment strategies focussing on identifying the degree of difficulty performing daily tasks on an individual patient to patient basis. Vetoquinol says its pain monitoring system is based on similar principles.
Robert Simpson, Product Manager for Cimalgex said: "The objective assessment of clinical outcomes are a continuing challenge in veterinary medicine; this is particularly true in chronic painful conditions such as osteoarthritis. Use of our Client Specific Outcome Measures form will allow vets and pet owners to more efficiently assess treatment to ensure that the patient is receiving appropriate analgesia.
The form can be adapted to give bespoke outcome measures which are agreed in consultation with the owners. This activity will increase interaction with pet owners and could increase loyalty to the practice; it could also be really useful in geriatric clinics etc as a method of assessing pain outside of consultations in practices."
To find out more or to request a monitoring pad for your practice, contact your Vetoquinol Territory Manager or call 01280 825424.